Lee & Man Paper Manufacturing reports a **69.3% profit increase** to **HK$1.4 billion** for the first half of 2026, alongside a **21.3% revenue rise** to **HK$14.8 billion**. The company also announces a higher interim dividend. Results are unaudited and cover the period ending **30 June 2026**.
Valmet upgrades five tissue machines for **Lee & Man Paper Manufacturing Ltd.** by replacing shoe presses with its **Advantage ViscoNip** technology. The upgrades target mills in **Chongqing, Jiangxi, and Guangdong**, aiming to improve operational efficiency and product quality. The project reflects a shift toward advanced press systems in China’s tissue manufacturing sector.
Valmet supplies its **Advantage ViscoNip** press technology to **Lee & Man Paper Manufacturing Ltd.**, replacing five shoe presses across three mills in **Chongqing, Jiangxi, and Guangdong**. The upgrade targets improved efficiency in tissue production at the Chinese manufacturer’s facilities.
Lee & Man Paper forecasts a surge in consumer demand for paper products in China, signaling a more optimistic outlook for the industry in 2023. The company highlights shifting market dynamics as key drivers for increased paper production and consumption. Industry analysts cite rising demand for packaging and printing materials as primary growth catalysts.
Lee & Man Paper Manufacturing acquires Guang Kai for HK $404 million (about $52.1 million) to manage its tissue operations. The deal consolidates tissue production under Lee & Man’s portfolio, expanding its manufacturing capabilities in the sector.